PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth
Circulation Research · 07.07.2023 · 133 (2) · 138-157
DOI: 10.1161/circresaha.122.322264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 07.07.2023. Verfasst von Si Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine (S.C., J.C., W.D., D.M.M., C.Y.), University of Rochester School of Medicine and Dentistry, Rochester, NY. Hauptthemen laut MEDLINE: Cardiotoxicity, Ovarian Neoplasms. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Cyclic nucleotides play critical roles in cardiovascular biology and disease. PDE10A (phosphodiesterase 10A) is able to hydrolyze both cAMP and cGMP. PDE10A expression is induced in various human tumor cell lines, and PDE10A inhibition suppresses tumor cell growth. Chemotherapy drug such as doxorubicin (DOX) is widely used in chemotherapy. However, cardiotoxicity of DOX remains to be a serious clinical complication. In the current study, we aim to determine the role of PDE10A and the effect of PDE10A inhibition on cancer growth and cardiotoxicity induced by DOX.
Methods
We used global PDE10A knockout (KO) mice and PDE10A inhibitor TP-10 to block PDE10A function. DOX-induced cardiotoxicity was evaluated in C57Bl/6J mice and nude mice with implanted ovarian cancer xenografts. Isolated adult mouse cardiomyocytes and a human ovarian cancer cell line were used for in vitro functional and mechanistic studies.
Results
We found that PDE10A deficiency or inhibition alleviated DOX-induced myocardial atrophy, apoptosis, and dysfunction in C57Bl/6J mice. RNA sequencing study revealed a number of PDE10A-regulated signaling pathways involved in DOX-induced cardiotoxicity. PDE10A inhibition increased the death, decreased the proliferation, and potentiated the effect of DOX on various human cancer cells. Importantly, in nude mice with implanted ovarian cancer xenografts, PDE10A inhibition attenuated tumor growth while protecting DOX-induced cardiotoxicity. In isolated cardiomyocytes, PDE10A contributed to DOX-induced cardiomyocyte death via increasing Top2β (topoisomerase 2β) expression, mitochondrial dysfunction, and DNA damage by antagonizing cGMP/PKG (protein kinase G) signaling. PDE10A contributed to cardiomyocyte atrophy via potentiating FoxO3 (forkhead box O3) signaling via both cAMP/PKA (protein kinase A)- and cGMP/PKG-dependent signaling.
Conclusions
Taken together, our study elucidates a novel role for PDE10A in cardiotoxicity induced by DOX and cancer growth. Given that PDE10A has been already proven to be a safe drug target, PDE10A inhibition may represent a novel therapeutic strategy in cancer therapy, with effects preventing DOX-induced cardiotoxicity and simultaneously antagonizing cancer growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Medicine (S.C., J.C., W.D., D.M.M., C.Y.), University of Rochester School of Medicine and Dentistry, Rochester, NY.
- Now with Department of Cardiology, Ruijin Hospital (J.C.), Shanghai Jiao-Tong University School of Medicine, China.
- Institute of Cardiovascular Diseases (J.C.), Shanghai Jiao-Tong University School of Medicine, China.
- Department of Geriatrics, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, China (W.D.).
- Clinical and Translational Research (H.S.), University of Rochester School of Medicine and Dentistry, Rochester, NY.
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY (H.Y.).
ORCID-Profile: Si Chen, Deanne M Mickelsen, Hangchuan Shi, Sparsh Kumar, Chen Yan
Förderung
- NHLBI NIH HHS
Zitieren
APA
Chen, S., Chen, J., Du, W., Mickelsen, D. M., Shi, H., Yu, H., Kumar, S., & Yan, C. (2023). PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth. Circulation Research, 133(2), 138-157. https://doi.org/10.1161/circresaha.122.322264
Vancouver
Chen S, Chen J, Du W, Mickelsen DM, Shi H, Yu H, et al. PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth. Circulation Research. 2023;133(2):138-157. doi:10.1161/circresaha.122.322264
BibTeX
@article{Chen2023,
author = {Chen, Si and Chen, Jiawei and Du, Wenting and Mickelsen, Deanne M and Shi, Hangchuan and Yu, Han and Kumar, Sparsh and Yan, Chen},
title = {PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth},
journal = {Circulation Research},
year = {2023},
volume = {133},
number = {2},
pages = {138--157},
doi = {10.1161/circresaha.122.322264}
}
EUVIMED